Closure of Trading Window
Filed with BSE · · 1 page · English
Summary by 6ix AI
Venmax Drugs & Pharmaceuticals Ltd. has announced the closure of its trading window for insiders, effective from a specified date following the declaration of its financial results. This action is in compliance with regulations regarding insider trading and the company's own code of conduct. The company will notify the date of the board meeting to consider its upcoming financial results in due course.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release May 06 2026
- Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 06 2026
- Regulation 31(4) - SAST Disclosure
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 30 2026
Later from Venmax Drugs & Pharmaceuticals
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2026
- Announcement under Regulation 30 (LODR)-Allotment
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 29 2026
- Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals